How PlexusDx Supports Metabolic Optimization Beyond Weight Loss PlexusDx serves all 50 states without requiring insurance, membership fees, or pre-existing obesity diagnosis
The proportion of patients achieving 15% weight loss is also similar between mazdutide and tirzepatide, suggesting dual GLP-1/glucagon receptor agonism may approach or match GIP/GLP-1 dual agonism in metabolic benefit
So, in 2023, my PCP hooked me up with a doctor that would prescribe me semaglutide
Why medical supervision matters You can find peptides for sale online labeled for research use only. Those are not intended for human use, their quality is not verified, and using them without medical guidance is where people get into trouble
J Mol Med (Berl) (2017) 95(12):12839
The FDA has since expanded its approved uses to include reducing cardiovascular risks in adults with heart disease and treating a serious liver condition called MASH (metabolic-associated steatohepatitis), a serious liver condition